How 23 Died in Norway After Receiving Pfizer COVID-19 Vaccine – Officials

By Our Reporter New York (Precise Post) – Health officials in Norway said that twenty-three people died within days of receiving their first dose of the Pfizer COVID-19 vaccine, with 13 of those deaths — all nursing home patients — apparently related to the side effects of the shots. Common reactions to the vaccine, including fever and nausea, “may have contributed to a fatal outcome in some frail patients,” Sigurd Hortemo, chief physician at the Norwegian Medicines Agency, said in a Friday statement. All 13 were nursing home patients and at least 80 years old. While officials aren’t expressing serious concern, they are adjusting their guidance on who should receive the vaccine. The news comes just over a week after officials reported the deaths of just two nursing home residents after they received the Pfizer jab. More than 30,000 people in Norway have received the first shot of the Pfizer or Moderna coronavirus vaccine in the Scandinavian country since late last month, according to official figures. “We are not alarmed by this,” Steinar Madsen, medical director with the agency, told …

How 23 Died in Norway After Receiving Pfizer COVID-19 Vaccine – Officials Read More

6th Vaccine Contract: Moderna to Manufacture, Deliver 100m Doses of Coronavirus Vaccine – Trump

By Francis Etuko Abuja (Precise Post) -President Donald Trump on Tuesday announced a $1.5 billion contract with US biotech company Moderna for 100 million doses of an eventual coronavirus vaccine, the sixth such deal reached since May. “I’m pleased to announce that we have reached an agreement with Moderna to manufacture and deliver 100 million doses of their coronavirus vaccine candidate,” Trump said at a White House news conference. “The federal government will own these vaccine doses, we’re buying them.” “We’re on track to rapidly-produce 100 million doses as soon as the vaccine is approved, and up to 500 million shortly thereafter, so we’ll have 600 million doses,” he added. Moderna, in partnership with the US National Institutes of Health (NIH), is conducting Phase 3 clinical trials of a vaccine candidate and manufacturing of vaccine doses will take place while the trials are underway. Handout picture released by the Sao Paulo State Government press office showing a volunteer receiving the COVID-19 vaccine during the trial stage of the vaccine produced by the Chinese company Sinovac Biotech at the Hospital das …

6th Vaccine Contract: Moderna to Manufacture, Deliver 100m Doses of Coronavirus Vaccine – Trump Read More